Latest Statin Stories
Patients with acute coronary syndrome who were treated with the experimental drug varespladib were more likely to experience additional cardiovascular events – including sudden death, heart attack and stroke – than those treated with placebo.
Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia, and colleagues determined the effects of varespladib, a drug that inhibits the enzyme secretory phospholipase A2 on cardiovascular risk in patients with acute coronary syndrome (ACS; such as heart attack or unstable angina).
Based on the largest comprehensive systematic review to date, researchers at the Perelman School of Medicine at the University of Pennsylvania concluded that available evidence does not support an association between statins and memory loss or dementia.
The Firm is now investigating Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of Lipitor. (PRWEB)
Cholesterol-lowering drugs should be prescribed to about 33 million more Americans, according to new guidelines for healthcare providers recently released by a joint committee from the American Heart Association and American College of Cardiology.
Attorney Paul d’Oliveira alerts patients taking Lipitor that recent studies have linked the drug to type 2 diabetes and other complications.
- A poem in which the author retracts something said in an earlier poem.